Analyzing R01 Anxiety: There Is Room For Optimism

United States biomedical research is the envy of all other nations. Its success and explosive growth are due to an efficient partnership between public funding and academic research. But this doesn't mean that the partnership is in every respect beyond improvement. Take, for instance, individual investigator-initiated grants (or R01s, in NIH vernacular). The R01 is the instrument by which new ideas can best be tried and developed. Appropriately, these grants have commanded an increasing share

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The R01 is the instrument by which new ideas can best be tried and developed. Appropriately, these grants have commanded an increasing share of the NIH budget; in the past five years alone the number of active R01s has increased by 25 percent.

R01s have evolved to become not only the cornerstone of biomedical research support, but also the prime factor in determining advancement of academic biomedical researchers. In awarding R01s, NIH study sections may now play a more important role in influencing who is appointed, promoted, or granted tenure than do promotion committees.

R01s have also come to provide an increasing proportion of the funds for pre- and postdoctoral training, which carries advantages as well as problems. While it can be argued that training funded by an R01 educates at the leading edge of science, this arrangement places in doubt whether that training is in the broadest educational interest ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Douglas Kelly

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo